Skip to main content

Table 4 Bevacizumab possibly related adverse events

From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

 

Grade

       
 

1

2

3

4

 

n

%

n

%

n

%

n

%

Pulmonary embolism

-

-

-

-

-

-

1

1.9

Cardiac ischaemia

-

-

-

-

1

1.9

-

-

Epistaxis

4

7.6

1

1.9

    

Gastrointestinal bleeding

-

-

-

-

1

1.9

-

-

Hypertension

5

9.5

2

3.8

-

-

-

 

Proteinuria

7

13.2

4

7.6

-

-

-

-

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us